Q2 2026 13F · SEC CIK 1399770
Kohlberg Kravis Roberts & Co. L.P.
Hedge fundFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $5.5B
- Reported positions
- 17
- Top holdings a year, 3 yrs
- +43.5%
- Assets under management
- $399.9B
Kohlberg Kravis Roberts & Co. L.P. is a hedge fund that reported 17 positions worth $5.5B in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Brightspring Health Services I (BTSG, 34.3%), Schein Henry Inc Com (HSIC, 23.9%), Bridgebio Pharma Inc (BBIO, 18.1%). A portfolio copying its top holdings returned 43.5% a year over the last 3 years, against 20.4% for the S&P 500.
Kohlberg Kravis Roberts & Co. L.P. holdings all 17 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| BTSGBrightspring Health Services I | 34.3% | -35.9% | $1.9B |
| HSICSchein Henry Inc Com | 23.9% | +0.0% | $1.3B |
| BBIOBridgebio Pharma Inc | 18.1% | +0.0% | $987.7M |
| BVBrightview Hldgs Inc | 5.7% | +0.0% | $308.9M |
| CRGYCrescent Energy Company | 5.2% | +0.0% | $281.4M |
| NIQNiq Global Intelligence PLC | 5.1% | +0.0% | $280.7M |
| GMRSGmr Solutions Inc | 4.2% | — | $228.6M |
| KREFKkr Real Estate Fin Tr Inc | 1.3% | +0.0% | $68.4M |
| PSKYParamount Skydance Corp | 1.0% | +0.0% | $54.6M |
| BHCBausch Health Cos Inc | 0.5% | +0.0% | $25.8M |
| OXLCOxford Lane Cap Corp | 0.3% | -44.4% | $15.5M |
| FSKFs Kkr Capital Corp | 0.2% | +0.0% | $10.3M |
| TEMTempus Ai Inc | 0.1% | +0.0% | $6.8M |
| NCLHNorwegian Cruise Line Hldgs | 0.1% | +0.0% | $5.8M |
| SPYState Str Spdr S&p 500 ETF T | 0.1% | — | $4.4M |
| CHRSCoherus Oncology Inc | 0.1% | +0.0% | $4.2M |
| VSECUVse Corp | 0.0% | +0.0% | $461K |
What Kohlberg Kravis Roberts & Co. L.P. bought and sold in Q2 2026, against Q1 2026.
New positions
- GMRS Gmr Solutions Inc4.2% of 13F
- SPY State Str Spdr S&p 500 ETF T0.1% of 13F
Added to
No position grew by more than 5%.
Reduced
- OXLC Oxford Lane Cap Corp-44.4% shares
- BTSG Brightspring Health Services I-35.9% shares
Sold out
- PPLC Ppl Corpwas 0.0%
Share counts compared with the Q1 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- +79.0% /yr
- S&P 500 +20.1%
- 3 years
- +43.5% /yr
- S&P 500 +20.4%
- 5 years
- +16.1% /yr
- S&P 500 +11.6%
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $5.5B | 17 |
| Q1 2026 | $5.1B | 16 |
| Q4 2025 | $5.9B | 14 |
| Q3 2025 | $5.6B | 16 |
| Q2 2025 | $4.4B | 15 |
| Q1 2025 | $3.9B | 13 |
| Q4 2024 | $3.1B | 10 |
| Q3 2024 | $6.8B | 13 |
| Q2 2024 | $2.7B | 14 |
| Q1 2024 | $3.3B | 15 |
| Q4 2023 | $2.8B | 17 |
| Q3 2023 | $2.4B | 19 |
Questions about Kohlberg Kravis Roberts & Co. L.P.'s portfolio
What stocks does Kohlberg Kravis Roberts & Co. L.P. own?
Kohlberg Kravis Roberts & Co. L.P.'s latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 17 positions worth $5.5B. The largest are Brightspring Health Services I (BTSG) at 34.3%, Schein Henry Inc Com (HSIC) at 23.9%, Bridgebio Pharma Inc (BBIO) at 18.1%, Brightview Hldgs Inc (BV) at 5.7% and Crescent Energy Company (CRGY) at 5.2%.
What did Kohlberg Kravis Roberts & Co. L.P. buy last quarter?
In Q2 2026, Kohlberg Kravis Roberts & Co. L.P. added a new position in Gmr Solutions Inc (GMRS) and a new position in State Str Spdr S&p 500 ETF T (SPY), compared with its Q1 2026 filing.
What did Kohlberg Kravis Roberts & Co. L.P. sell last quarter?
In Q2 2026, Kohlberg Kravis Roberts & Co. L.P. sold all of Ppl Corp (PPLC), Oxford Lane Cap Corp (OXLC) (-44.4% shares) and Brightspring Health Services I (BTSG) (-35.9% shares), compared with its Q1 2026 filing.
How has Kohlberg Kravis Roberts & Co. L.P.'s portfolio performed?
A portfolio copying Kohlberg Kravis Roberts & Co. L.P.'s 20 largest 13F holdings each quarter, from the day each filing was public, returned +43.5% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +79.0% against +20.1%. Over 5 years: +16.1% a year against +11.6%.
When is Kohlberg Kravis Roberts & Co. L.P.'s next 13F filing due?
13F filings are due 45 days after each quarter ends. Kohlberg Kravis Roberts & Co. L.P.'s filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does Kohlberg Kravis Roberts & Co. L.P. manage?
Kohlberg Kravis Roberts & Co. L.P. reported $399.9B of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $5.5B.